Evidence map›Paper›PMID 33157180›Full record

ArticleAmerican journal of infection control2021

Unintended consequences of infection prevention and control measures during COVID-19 pandemic.

Liang En Ian Wee, Edwin Philip Conceicao, Jing Yuan Tan, Kamini Devi Magesparan, Ismawati Binte Mohamad Amin, Bushra Binte Shaik Ismail, Hui Xian Toh, Pinhong Jin, Jing Zhang, Elaine Geok Ling Wee and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of infection control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 6 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 6 syntheses or guidelines pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Liang En Ian WeeSinghealth Infectious Diseases Residency, Singapore; Department of Infectious Diseases, Singapore General Hospital, Singapore. Electronic address: ian.wee@mohh.com.sg.
Edwin Philip ConceicaoDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Jing Yuan TanDepartment of Internal Medicine, Singapore General Hospital, Singapore.
Kamini Devi MagesparanDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Ismawati Binte Mohamad AminDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Bushra Binte Shaik IsmailDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Hui Xian TohDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Pinhong JinDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Jing ZhangDepartment of Nursing Speciality Care Unit, National Heart Centre, Singapore.
Elaine Geok Ling WeeDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Sheena Jin Min OngDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Gillian Li Xin LeeDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Amanda En-Min WangDepartment of Nursing Speciality Care Unit, National Heart Centre, Singapore.
Molly Kue Bien HowDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Kwee Yuen TanDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Lai Chee LeeDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Poh Choo PhoonDepartment of Nursing Speciality Care Unit, National Heart Centre, Singapore.
Yong YangDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
May Kyawt AungDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Xiang Ying Jean SimDepartment of Infectious Diseases, Singapore General Hospital, Singapore; Department of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Indumathi VenkatachalamDepartment of Infectious Diseases, Singapore General Hospital, Singapore; Department of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore.
Moi Lin LingDepartment of Infection Prevention and Epidemiology, Singapore General Hospital, Singapore. Electronic address: ling.moi.lin@singhealth.com.sg.
Singapore General Hospital · SGNational Heart Centre Singapore · SGSingHealth · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the current COVID-19 pandemic, aggressive Infection Prevention and Control (IPC) measures have been adopted to prevent health care-associated transmission of COVID-19. We evaluated the impact of a multimodal IPC strategy originally designed for the containment of COVID-19 on the rates of other hospital-acquired-infections (HAIs). METHODOLOGY: From February-August 2020, a multimodal IPC strategy was implemented across a large health care campus in Singapore, comprising improved segregation of patients with respiratory symptoms, universal masking and heightened adherence to Standard Precautions. The following rates of HAI were compared pre- and postpandemic: health care-associated respiratory-viral-infection (HA-RVI), methicillin-resistant Staphylococcus aureus, and CP-CRE acquisition rates, health care-facility-associated C difficile infections and device-associated HAIs.

resultsEnhanced IPC measures introduced to contain COVID-19 had the unintended positive consequence of containing HA-RVI. The cumulative incidence of HA-RVI decreased from 9.69 cases per 10,000 patient-days to 0.83 cases per 10,000 patient-days (incidence-rate-ratio = 0.08; 95% confidence interval [CI] = 0.05-0.13, P< .05). Hospital-wide MRSA acquisition rates declined significantly during the pandemic (incidence-rate-ratio = 0.54, 95% CI = 0.46-0.64, P< .05), together with central-line-associated-bloodstream infection rates (incidence-rate-ratio = 0.24, 95% CI = 0.07-0.57, P< .05); likely due to increased compliance with Standard Precautions. Despite the disruption caused by the pandemic, there was no increase in CP-CRE acquisition, and rates of other HAIs remained stable.

conclusionsMultimodal IPC strategies can be implemented at scale to successfully mitigate health care-associated transmission of RVIs. Good adherence to personal-protective-equipment and hand hygiene kept other HAI rates stable even during an ongoing pandemic where respiratory infections were prioritized for interventions.

Indexed as

SARS-CoV-2Catheterization, Central VenousCatheter-Related InfectionsCOVID-19Cross InfectionHumansInfection ControlMethicillin-Resistant Staphylococcus aureusRespiratory Tract InfectionsStaphylococcal InfectionsUnited StatesHealthcare associated infectionsinfection controlMRSASARS-CoV-2Surveillance

Identifiers

PMID33157180
PMCPMC7610096
OpenAlexW3097667937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.